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Results: The LV ejection fraction increased from 24.5 ± 7.8 % at randomisation (rand) to 
30.0 + 12.1% after I year of BIV (p<0.05). LV function by Doppler echo i.e. diastolic fill- 
ing time (DFT), left ventdcular enddiastolic and systolic diameters (LVEDD, LVESD) and 
mitrai regurgitation (MR) are given in the Figure. 
Conclusion: In parallel with a sustained clinical improvement left ventdcular function pro- 
greselvely improved by biventricular pacing in these patients with severe heart failure, 
sinus rhythm and intraventricular conduction delay. 
Rand BIV-CO BIV 9M BIV 12M 
n=67 n=48 n=45 n=43 
LVEDD (mm) 74+10 69±11 *** 68+10"** 67+12*** 
LVESD (mm) 63±10 58± 12*** 56±11 ** * 57±12*** 
MR area (cm =) 7.8±7.8 5.6±8.3 4.9-3:4.6** 4.3¢4.0"* 
DFT (ms) 375±136 430~137" 471+154"* 425±129" 
M=months, *p<O.05, **p<0.01, ***p<0.001, all compared to randomization 
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815-2 Do Heart Fai lure Pat ients  With Right Bundle Branch 
Block Benefit From Cardiac Resynchronization 
Therapy?  Ana lys i s  o f  the  MIRACLE Study  
Juan M. Arenda. Jr.. Anne B. Curtis, Jamie B. Conti, Susan Petereon-Stejskal, University 
of Florida Department of Medicine, Galnesville, Florida. 
Background: Cardiac rasynchronization therapy (CRT) through atriel-tdggered biventricular 
pacing has been proposed as a treatment for heart failure patients with intraventricular con- 
ductlon delays. Previous studies wi~ small heart failure patiant populations have predominan- 
tsb/included patients with left bundle branch block (LBBB) rather than dght bundle branch 
block (RBBB). 
Objective: To determine whether there is a difference in response to CRT between heart fail- 
ure patients with LBBB and heart failure patients with RBBB. 
Methods: The Multi.center InSync Randomized Clinical Evaluation is a large, randomized, 
double-blind study to assess the efficacy of CRT in advanced heart failure patients with a QRS 
duration of >130 msec. In this trial, heart failure patients with CRT had improvement in New 
York Heart Association (NYHA) functional class, quality of life score and distance walked in 6 
minutes compared to patients with no CRT. In this analysis, the changes in these pdmary end- 
points at 6 months from baseline were compared between heart failure patients with LBBB 
and heart failure patients with RBBB. 
RemJff~: Of the 219 patients who completed the 6-menth follow-up, 203 had LBBB, and 16 
had RBBB. Age gender, NYHA functional class, QRS duration, left ventricuiar ejection fraction, 
left ventdoular end diastolic diameter, and heart failure medications were the same at baseline 
for LBBB and RBBB gr~Jps. RBBB patients were more likely to be of Afncan American ethnic- 
ity (LBBB 80, RBBB 25% (p=0.0Ot)) and to have a higher resting heart rats (I_BBB 74 beats 
par minute, RBBB 82 beats par minute (/;=0.02)), There was no difference between groups 
with respect to changes in NYHA functional class (p=0.221), quality of life score (,o=0.315), or 
distance walked in 6 minutes (/:3=0.642). 
Conclusion: Heart failure patients with RBBB obtain the same benefits from CRT as heart 
failure patierds with LBBB. Heart failure patients with RBBB should not be excluded from CRT. 
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815-3 Upgrade to  B lventr lcu lar  Pac ing In Advanced Heart 
Failure Patients Prsvlously Implanted With a 
Conventional Pacemaker for a Class ical  Ind icat ion:  Is It 
Worth  It ? 
Chdstophe Leclercq, Chdstine Alonso, Florence Revault d'AIIonnas, Dominique Pavin, 
Philippe Mabo, Jean C. Daubed. University Hospital, Rennes, France. 
The therapeutic value of biventdcular (BIV) pacing has recently been validated in patients 
with advanced heart failure (AHF), wide QRS complex, and without any classical pace- 
maker (PM) indication. But is this new treatment also suitable for AHF patients previously 
implanted with a conventional PM for a classical indication, and presenting with wide paced 
QRS complex (> 200 ms) ? The aim of this study was to compare the Iong-tarm clinical 
effects of permanent BIV in 2 groups of patients : pts with a previously implanted PM sub- 
sequantly upgraded to BIV (PM+ ; n = 23) and pts without (PM- ; n = 92). Comparisons 
were performed between baseline and end FU under BIV in each group. 
Conclusion : Permanent BIV provided similar symptomatic relief in both AHF patients with 
or without previously implanted PM. While the age and AF prevalence were significantly 
higher in PM+ Lots, the mortality rate was identical in both groups. The magnitude of QRS 
reduction with BIV was significantly greater in PM+ pts. 
PM+ PM+ PM+ PM- PM- PM- 
Baseline P BIV Baseline P BIV 
Age (Years) 71 ± 7 66 ± 9 
AF/SS R 11/12 27/65 
FU time (m) 18 ± 11 19 ± 13 
NYHA class 3.3 ± 0.5 < 0.01 2.4 ± 1 3.3 ± 0.5 < 0.01 2.2 ± 0.7 
QRS (ms) 204 ± 30 < 0.01 157 ± t9 181 ± 23 < 0.01 158 ± 19 
Peak VO2 (ml/kg/min) 12±4 <0.01 16±3 13±5 <0.01 16±4 
LVEF (%) 20±8 <0.05 27±7 22¢8 <0.01 27±10 
Mortality (%) 19 21 
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815-4 Delayed Electrical Activation of the Left Septum and 
Lateral Wall In Left Bundle Branch Block: Insight From 
3-D Electroanatomlcal Mapping 
Apealo Audcchio. Christoph J. Geller, Sven Reek, Andreas Goetts, Hslmut U. Klein, Di~ 
Cardiology - University Hospital. Magdeburg, Germany. 
Background. The sequence of right and left ventdcular activation in patients with heart 
failure and left bundle branch block (LBBB) has not been characterized in detail. 
Methods. Using a 3-D electreanatomical nonfluoroscopic mapping system, the right (RV) 
and left (LV) ventdcular activation sequence was studied in 70 patients (48 males, mean 
age 61 +/- 7 yrs) with LBBB, dilated cardiomyopathy of any etiology, and heart failure 
(NYHA class >ti). The total RV and LV activation time, the time to LV breakthrough (LV- 
B), and the time to LV free wall activation (LV-FW) was analyzed. The area delimited by 
the isochrenal line corresponding to the last 1/3 of LV total activation was calculated 
(Area of Delayed Activation). This area was normalized (%) to the total LV surface celcu- 
;ated by the mapping system. 
Results. The LV-B was largely different in the study cohort: 14 patients (20%) have had a 
normal (<20 msec) LV-B (Group I), whereas a markedly prolonged LV-B (range 30-70 
msec) was present in 56 patients (Group II). Only the duration of the QRS complex distin- 
guished the 2 Groups: 139+/-20 msec, and 170+/-26 msec (p<0.01), in Group I and II 
respectively. The total RV activation time was similar in Group I (83 +/- 5 msec) and 
Group II (78 +/- 22, p=NS). The total LV activation time also did not differ between Group 
I (120 +/- 23 rnsec) and Group ti (110 +/- 17, p=NS). The LV activation at superior, ante- 
rior, and inferior wall was similar between the 2 Groups. In contrast, the LV-FW time was 
significantly shorter in Group I (47 +/- 11 msec) than in Group II (57 +/- 13 msec, p<0.05). 
Furthermore, the extent of the area of delayed LV activation normalized for the total LV 
surface was much larger in Group II (36 +/-2%) than in Group I (31 +/-3%), p<0.05). 
Conclusions. Despite similar RV and LV total activation time in patients with LBBB and 
heart failure, abnormal electrical activation are selectively localized at the LV septum and 
LV-FW. Patients with LBBB and QRS >150 msec frequently have had a prolonged LV 
breakthrough time and larger area of delayed ventricular activation than patients with 
LBBB, but narrow QRS duration (120-150 msec). These results might have important 
clinical implications for candidate to cardiac resynchronization therapy. 
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815-5 Echocard iograph ic  and Neurohormons l  Pred ictors  of  
Left  Ventr icu lar  Reverse Remodel ing  Af ter  Blventricular 
Pacing fo r  Heart  Fai lure 
Cheuk-Man Yu, Gary M. Nicholls, John E. Sanderson, Steve Fisher, Man-Oi Tang, Hong 
Lin, Chu-Pak Lau. University of Hong Kong, Hong Kong, t-long Kong, University of 
Otago, Christchurch, New Zealand. 
Background: Biventdcular pacing has been demonstrated recently to result in left ventric- 
ular (LV) reverse remodeling (RR) in heart failure patients with wide QRS complexes. 
This study investigated the clinical, echocardiographic and neurohormonal predictors of 
RR after biventricular pacing therapy. Methods: Nineteen patients (mean age: 82 ± 14 
yrs, 14 males) received biventdcular pacing therapy for 3 months were studied by 
echocardiogrephy with tissue Doppler imaging and same day plasma neurohormones 
were assayed. Results: There were 10 responders of RR (defined as reduction of LV 
end-systolic volume [LVVs] by >10%) and 9 non-responders (change in LVVs <10%). 
The ejection fraction was increased in the rasponders, but was unchanged in the non- 
responders (13.4 ± 9.6 Vs -3.0 ± 7.8%, p = 0.001). The responders also had more severe 
LV systolic asynchreny as shown by the standard deviation of the time to peak systolic 
contraction of the 12 LV segments (Ts-SD) (39.4 ± 9.8 Vs 23.4 ± 8.9 ms, p = 0.003). The 
plasma concentration of brain natduretic paptide (BNP) and endothelin were also lower 
in responders than non-responders. Significant predictors of RR include a wide QRS 
duration (r = -0.52, p = 0.02), a large pre-paclng LVVs (r = -0.58, p = 0.009), more severe 
systolic asynchrony (r = -0.70, p = 0.002), and low BNP (r = 0.66, p = 0.02) and endothe- 
lin levels (r = 0.69, p = 0.01 ). By stepwise multiple regression analysis, independent pre- 
dictors of RR include LVVs (beta = -0.11, p = 0.02), Ts-SD (beta = -0.83, p = 0.03), and 
BNP level (beta = 0.31, p = 0.008). When combining Ts-SD and BNP, the sensitivity and 
specificity for predicting a successful RR were 89% and 100%, respectively. Conclu- 
sions: LV RR after biventdcular pacing was found in those with more severe LV enlarge- 
ment and systolic asynchrony, but relatively low BNP levels, suggesting that pacing 
therapy should be initiated before reaching end-stage heart failure biochemically. 
